CN · Field Sheet
FIELD SHEET — CHAMOMILE MFI-CHAMOM-20261019-FS
Survey index / CHAMOMILE

Chamomile.

Matricaria chamomilla, Matricaria recutita, Matricaria perforata, Chamaemelum nobile
Asteraceae infusion; sleep, anxiety and GI literature.
SEALED MFI-CHAMOM-20261019-FS · RELEASED 2026-10-19
SHEET FINGERPRINTMFI-CHAMOM-20261019-FS
381INCLUDED
1,981EXCLUDED
73DUPLICATE
143NON-TRANSFERABLE
1OUT OF CUTOFF
Survey totalsScroll ↓
2,579records surveyed
381studies
29claims graded
133observations
8,777graph nodes

Claim records

2 shown · bounded preview
RECORD PREVIEW · FIELD RECORD ×2BOUNDED — REAL RELEASED DATA
CLAIM · CLM-42cd2c5fc1d202aeGRADE VERY_LOW
chamomile constituents — inflammation
direction BENEFIT · dose 100 mg/kg · duration UNSPECIFIED
Grade basis — weakest-link ceilings
VERY_LOWdesign
LOWdirectness
LOWextraction
VERY_LOWconfidence
MODERATEmethodology
MODERATEconsistency
MODERATEnumeric
5bound studies
Bound studies (4 shown of 5)
STU-474686b0994fdf5c
IN_VITRO · IN_VITRO · 2026 · RoB INSUFFICIENT_INFORMATION
4 endpoints
STU-5b1760657a0d7ea4
ANIMAL · ANIMAL · 2025 · RoB INSUFFICIENT_INFORMATION
3 endpoints
STU-7b070637055f53dd
ANIMAL · ANIMAL · 2024 · RoB INSUFFICIENT_INFORMATION
6 endpoints
STU-a083a78878e4dccf
IN_VITRO · IN_VITRO · 2011 · RoB INSUFFICIENT_INFORMATION
6 endpoints
Quantitative observations
observation 100 mg/kg · validated
observation p < 0.05 · validated
observation p < 0.05 · validated
Opposition screen
SCREEN · 13 candidates considered · 3 bound as opposing
SYNTHESIS SYN-9ef75ed1f3c0d6 — outcome QUALITATIVE_ONLY · BENEFIT ×5 · not_assessed_quantitatively · 5 members
PROVENANCE → epmc:42201886, epmc:40005942, epmc:38476603 · PKG ae30b359ffffa9cb…
CLAIM · CLM-e7030fa06f14bf4bGRADE VERY_LOW
chamomile constituents — antioxidant
direction BENEFIT · dose 0.5 g/kg; 100 mg/kg · duration 16 weeks
Grade basis — weakest-link ceilings
VERY_LOWdesign
LOWdirectness
LOWextraction
VERY_LOWconfidence
MODERATEmethodology
MODERATEconsistency
MODERATEnumeric
5bound studies
Bound studies (4 shown of 5)
STU-03ac07d5490c7837
IN_VITRO · IN_VITRO · 2025 · RoB INSUFFICIENT_INFORMATION
1 endpoints
STU-16969009cf5fb801
ANIMAL · ANIMAL · 2025 · 16 weeks · RoB INSUFFICIENT_INFORMATION
1 endpoints
STU-a083a78878e4dccf
IN_VITRO · IN_VITRO · 2011 · RoB INSUFFICIENT_INFORMATION
6 endpoints
STU-b7899dfa89e9c8cf
ANIMAL · ANIMAL · 2026 · RoB INSUFFICIENT_INFORMATION
4 endpoints
Quantitative observations
observation 0.5 g/kg · validated
observation p < 0.0001 | p < 0.0001 | p < 0.0009 | p < 0.05 · failed extraction
observation 100 mg/kg · validated
Opposition screen
SCREEN · 14 candidates considered · 3 bound as opposing
SYNTHESIS SYN-b4fad6b01224f7 — outcome QUALITATIVE_ONLY · BENEFIT ×5 · not_assessed_quantitatively · 5 members
PROVENANCE → epmc:40123219, epmc:41459911, crf:10.1158/1538-7445.am2011-4626 · PKG ae30b359ffffa9cb…
Bounded preview — representative records only. The full release ships 29 claims and 133 observations.